Endoscopic Salvage Following Radiotherapy for Oesophageal Cancer: A Systematic Review.

Clin Oncol (R Coll Radiol)Jul 21, 2026 (epub)

H L Keenan, R A Brooks, C M Jones

✦ AI-curated · Sources linked

In 30 seconds

This systematic review evaluated the safety and efficacy of endoscopic salvage procedures following definitive chemoradiotherapy (dCRT) for locally advanced oesophageal squamous cell carcinoma (OSCC) and adenocarcinoma (OAC). It included 45 studies with 1970 lesions, reporting 3-year overall survival rates of 35-81% and 5-year rates of 36-75%. The findings suggest endoscopic salvage is a feasible alternative to oesophagectomy.

Key findings

  • 3-year overall survival rates post-salvage ranged from 35-81%.
  • 5-year overall survival rates post-salvage ranged from 36-75%.
  • Stricture occurred in 0-21% of cases following endoscopic resection.
  • Chest pain was reported in 25-54.9% of patients after photodynamic therapy.

Why it matters

Understanding the outcomes of endoscopic salvage procedures can help clinicians make informed decisions for patients with residual or recurrent oesophageal cancer after dCRT, particularly for those unfit for more invasive surgeries.

Source

Published in Clin Oncol (R Coll Radiol). This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Gastroenterology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.